Top Markets
#1 Seeker Seeker +125.76%
#2 AI XOVIA AI XOVIA +108.37%
#3 MowCat MowCat +106.88%
#4 Helium Helium +78.29%
#5 Pons Pons +45.97%
#6 UnifAI Network UnifAI Network +35.36%
#7 Zora Zora +32.41%
#8 Bounce Bounce +21.84%
#9 Zylo Ecosystem Zylo Ecosystem +20.33%
#10 Tensor Tensor +16.98%
Coin of the day
Seeker Seeker
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

300534
Classifica tra le azioni #11766
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a... Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a pharmaceutical enterprise, focusing on the research, development, manufacturing, and commercialization of traditional Chinese medicines, health supplements, and active pharmaceutical ingredients (APIs). Its extensive product line includes therapeutic remedies such as Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Astragalus Angelica capsules, and berberine tannin films. Beyond its core manufacturing, the company is actively involved in the cultivation, procurement, processing, and distribution of Chinese medicinal raw materials. Its operations further encompass project investment and management, alongside the import, sale, logistics, and export of pharmaceutical goods. Established in 2002, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is headquartered in Lanzhou, China.
Prezzo delle azioni
$2.18
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$661.58M
Variazione (1 giorno)
-13.01%
Variazione (1 anno)
52.92%
Paese
CN
Scambia Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

Categoria

Healthcare
Ricavi di Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN